BK polyomavirus (BKV) is ubiquitous in the human population, infecting children without obvious symptoms, and persisting in the kidney in a latent state. In immunosuppressed patients, BKV is reactivated and excreted in urine. BKV isolates have been classified into four subtypes (I-IV) using either serological or genotyping methods. To elucidate the subtypes of BKV prevalent in Japan, the 287 bp typing region in the viral genome was PCR-amplified from urine samples of 45 renal transplant (RT) and 31 bone-marrow transplant (BMT) recipients. The amplified fragments were subjected to a phylogenetic or RFLP analysis to determine the subtypes of BKV isolates in urine samples. Subtypes I, II, III and IV were detected, respectively, in 70-80, 0, 2-3 and 10-20 % of the BKV-positive patients in both patient groups. This pattern of distribution was virtually identical to patterns previously demonstrated in England, Tanzania and the United States, suggesting that BKV subtypes are distributed similarly in various human populations. Furthermore, transcriptional control regions (TCRs) were PCR-amplified from the urine samples of 25 RT and 20 BMT recipients, and their nucleotide sequences were determined. The basic TCR structure (the so-called archetype configuration) was observed in most isolates belonging to subtypes I, III and IV (subtype II isolates were not available), albeit with several nucleotide substitutions and a few single-nucleotide deletions (or insertions). Only three TCRs carried extensive sequence rearrangements. Thus, it was concluded that the archetypal configuration of the BKV TCR has been conserved during the evolution of BKV.
INTRODUCTION
Human polyomavirus BK virus (BKV) was first isolated in the urine of a renal transplant (RT) patient (Gardner et al., 1971) . Seroepidemiological surveys conducted in various countries have since demonstrated that this virus is ubiquitous in humans (Knowles, 2001) . Infection most frequently occurs during childhood, with adult levels of seroprevalence (65-90 %) reached between the ages of 5 and 10 years (Knowles, 2001) . It is thought that BKV persists in renal tissue (Heritage et al., 1981; Chesters et al., 1983) . The urinary excretion (viruria) of BKV is rather rare in immunocompetent individuals, but is frequent in immunocompromised individuals, including organ transplant recipients, HIV-infected patients and pregnant women (Knowles, 2001) . In immuocompromised patients, the reactivation of BKV sometimes results in renal dysfunction, such as BKV-associated nephropathy (Moens & Rekvig, 2001) .
BKV is the only primate polyomavirus that has subtypes distinguishable by immunological reactivity (Knowles, 2001) . Knowles et al. (1989) introduced a typing scheme using a set of rabbit antisera against various isolates shown to differ from the prototype BKV (Gardner strain) either
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antigenically or by restriction enzyme cleavage patterns. However, this typing method requires BKV isolates previously obtained by viral culture. Jin et al. (Jin et al., 1993b; Jin, 1993) developed a direct and convenient method based on the polymerase chain reaction. A partial VP1 gene sequence probably containing nucleotide substitutions responsible for antigenic diversity (Jin et al., 1993a) was PCR-amplified from clinical samples (usually urine specimens), and the resultant amplified fragments were subjected to either DNA sequencing or restriction enzyme analysis. Based on these analyses, Jin et al. (Jin et al., 1993b; Jin, 1993) classified various laboratory BKV strains as well as clinical isolates into four subtypes, I-IV, which corresponded well to groups based on the serological assay.
It is of interest to examine whether a correlation exists between BKV subtypes and human populations, as JC virus (JCV), a related human polyomavirus, shows a close correlation between subtypes and human populations (Agostini et al., 2001; Yogo et al., 2004) . The distribution of BKV subtypes has been studied in several patient groups in England (Jin et al., 1993b (Jin et al., , 1995 , Italy (Di Taranto et al., 1997) , Tanzania (Agostini et al., 1995) and the United States (Baksh et al., 2001) , and it was found that subtype I was predominant in all of these studies. Nevertheless, no information is available about the distribution pattern of BKV subtypes in Asia. To gain an overall picture of the distribution of BKV subtypes in the world, here, we genotyped BKV isolates detected in the urine of RT and bone-marrow transplant (BMT) recipients in Japan.
The BKV genome has a transcriptional control region (TCR) between the origin of replication and the start site of the late leader protein (agnoprotein) (Seif et al., 1979) . The BKV TCR readily undergoes DNA sequence rearrangement during passage of the virus in cell culture (Yoshiike & Takemoto, 1986; Hara et al., 1986; Rubinstein et al., 1987) . Therefore, the TCRs of BKV isolates obtained by viral culture could contain alterations introduced in vitro. In contrast, those obtained by molecular cloning or PCR should represent naturally occurring BKV TCRs. Analysis of BKV TCRs isolated using the latter method thus revealed that naturally occurring BKV TCRs have a common structure named the archetype (Moens & Rekvig, 2001 ).
Nevertheless, information about BKV TCRs has been obtained mainly for subtype I, as this subtype is most prevalent (Knowles, 2001) . A complete DNA sequence was reported for a strain (AS) belonging to subtype III, but this strain was isolated by viral culture (Coleman et al., 1980) . Indeed, AS carries a 32 bp deletion encompassing an origindistal region of the TCR and the start site of the agnogene (Tavis et al., 1989) . Furthermore, Negrini et al. (1991) detected AS-like TCRs in 2 of 13 isolates from the urine of BMT recipients, but they did not sequence the origindistal portion of these TCRs. Thus, the relationship between BKV subtype and TCR structure remains to be clarified. In this study, we examined TCR structures for many isolates belonging to various subtypes of BKV.
METHODS
Urine samples. Urine samples were collected with informed consent from 186 RT recipients, who underwent a renal transplantation at Tokyo Women's Medical University, University of the Ryukyus Faculty of Medicine, Oyokyo Kidney Research Institute and Iwate Medical University School of Medicine. No patient had active graft rejection episodes or developed nephropathy during the study. About 40 ml urine was collected in a 50 ml plastic tube that contained 0?5 ml 0?5 M EDTA, pH 8?0, and the samples were sent to the Department of Urology, Faculty of Medicine, University of Tokyo, where DNA was extracted as described previously (Kitamura et al., 1990) . Urine samples previously obtained from BMT recipients and shown to contain BKV DNA (Akiyama et al., 2001) were also used.
PCR. The 287 bp typing region and the TCR were amplified from urinary DNA by PCR using ProofStart DNA polymerase (Qiagen). The 287 bp region spanned from 1650 to 1936 nt in the BKV (Dunlop) genome (GenBank accession no. V01108; NCBI no. NC_001538), and contained the whole effective sequence within the 327 bp typing region (Jin et al., 1993b) . Primers used to amplify the typing region were 327-1PST (59-GCCTGCAGCAAGTGCCAAAAC-TACTAAT-39; nt 1630-1649) and 327-2HIN (59-GCAAGCTTGCA- TGAAGGTTAAGCATGC-39; nt 1956 -1937 . Those used to amplify the TCR were RR-1PST (59-GCCTGCAGGCCTCAGAAAAAGCCT-CCACAC-39; nt 49-72) and RR-2HIN (59-CGAAGCTTGTCGTG-ACAGCTGGCGCAGAAC-39; nt 412-391). Underlined nucleotides were added to create a PstI or HindIII cleavage site. Primers 327-1PST and 327-2HIN were similar to 327-1 and 327-2 reported by Jin et al. (1993b) but carried restriction sites for PstI and HindIII, respectively. The total reaction volume of 50 m1 contained 2?5 ml crude viral DNA, 1?25 U ProofStart DNA polymerase (Qiagen), 200 mM each dNTP, 0?5 mM primers and PCR buffer, supplied by the manufacturer. After activation at 95 uC for 5 min, the amplification reaction was performed for 50 cycles. The cycle profile was 94 uC for 1 min, 55 uC for 1 min and 72 uC for 2 min. Both activation and amplification were carried out in a Thermal Sequencer (Asahi Techno Glass Corporation).
Molecular cloning. The amplified fragments were cleaved with a combination of HindIII and PstI (Takara Bio), and ligated to pBluescript II SK (+) (Stratagene), which was previously digested with HindIII and PstI and dephosphorylated with bacterial alkaline phosphatase (Takara Bio). The ligation products were used to transform competent cells (Escherichia coli HB101; Takara Bio). Recombinant plasmids were prepared using a plasmid mini kit (Qiagen).
Sequencing. Purified plasmids were used for a cycle sequencing reaction set up using the DYEnamic ET Terminator cycle sequencing kit (Amersham Biosciences). Primers used were the T3 and T7 promoters (Toyobo). The primers were added to a final concentration of 0?25 pmol ml 21 in a final reaction volume of 20 ml. The cycling conditions were 25 cycles of 30 s at 96 uC, 15 s at 50 uC and 60 s at 60 uC. The reaction was terminated at 4 uC. Cycle sequencing products were purified on Centri-Sep columns (Princeton Separations). DNA sequencing was performed using an automated sequencer (ABI Prism 373S DNA sequencer; Applied Biosystems).
Phylogenetic analysis. A neighbour-joining (NJ) phylogenetic tree (Saitou & Nei, 1987) was constructed using the CLUSTAL W program (Thompson et al., 1994) . Divergences were estimated with the two-parameter method (Kimura, 1980) . The phylogenetic tree was visualized using DendroMaker for Macintosh ver. 4.1 (Imanishi, 1998) . The confidence of branching patterns of the NJ trees was assessed based on 1000 bootstrap replicates (Felsenstein, 1985) .
RFLP analysis. Sequences of 287 bp typing fragments were available for several BKV isolates belonging to I-IV (Seif et al., 1979; Yang & Wu, 1979; Tavis et al., 1989; Sugimoto et al., 1990; Jin, 1993) . Using a computer program, we examined these 287 bp sequences, together with those determined in this study (see below), for the presence or absence of restriction sites that would identify the four BKV subtypes. It was found that RFLPs generated by three restriction enzymes, AluI, Cfr13I and RsaI, can be used to identify BKV subtypes (Table 1 ). The RFLP analysis involving these enzymes was carried out as follows. PCR mixtures were extracted with phenol and filtered through spin-columns containing Sephadex G-25 superfine (Amersham Biosciences). Typically, 2?5 ml aliquot of a purified PCR mixture was digested at 37 uC for 1 h with 10-20 U each enzyme. The digest was resolved by electrophoresis on a 3 % NuSieve agarose gel (Takara Bio) stained with ethidium bromide.
RESULTS

BKV subtypes prevalent in Japan
Using PCR to amplify the 287 bp typing region, we screened urine samples of 186 RT recipients for the presence of BKV DNA. We detected BKV DNA in 45 urine samples in total. We determined the subtypes of these BKV DNAs by phylogenetic analysis (n=27) and RFLP analysis (n=18). (We will describe the phylogenetic analysis in the following section.) We also determined the subtypes of BKV DNA previously detected in 31 urine samples from BMT recipients (Akiyama et al., 2001) by the phylogenetic method.
BKV subtype frequencies in the RT and BMT recipients analysed in this study are shown in Table 2 . The RT recipients were classified into three groups according to their geographical origins, and BKV subtype frequencies are shown for each of these groups (Table 2) . Subtypes I, III and IV were detected in 70-80, 2-3 and 10-20 %, respectively, of the BKV-positive patients in both patient groups. Nevertheless, subtype II was not detected in either RT or BMT recipients. Subtype distribution patterns were apparently similar among the two patient groups and geographical origins of patients (Table 2 ).
Phylogenetic analysis of BKV isolates based on the 287 bp sequences
We cloned 287 bp typing regions amplified from urine samples, and sequenced representative clones for each urine sample (Table 3) . We obtained single sequences from all urine samples examined. From these sequences, together with reference sequences reported previously (Table 4) , a phylogenetic tree was constructed using the NJ method (Saitou & Nei, 1987) . According to the resultant phylogenetic tree (Fig. 1) , all isolates detected in this study diverged into three clusters corresponding to subtype I, III and IV. Nevertheless, isolate SB (reference for subtype II) did not cluster with any of the present isolates. It should be noted that the grouping of isolates belonging to subtype I, III or IV was supported by higher bootstrap probabilities (95-100 %) (Fig. 1) . In addition, subtype I apparently subdivided into at least three subclusters, Ia, Ib and Ic. Ia contained one isolate from Sudanese and two isolates from Americans; Ib contained one isolate from a South African, one isolate from English, two isolates from Dutch and five isolates from Japanese; and Ic contained 41 isolates from Japanese. Bootstrap probabilities ranged from 63 to 86 %. 
TCR sequences detected from urine-derived isolates
We cloned TCRs amplified from 45 urine samples (Table 3) , and sequenced a few representative clones for each urine sample. We obtained single sequences from all urine samples examined. We also sequenced the TCRs of 2 complete BKV DNA clones (WW and MT-1) obtained directly from urine previously (Chauhan et al., 1984; Sugimoto et al., 1989) . Alignment of the resultant 47 sequences gave rise to 10 unique sequences, designated Seq-1 to Seq-10 (Fig. 2) . In Fig. 2 , Seq-1 (the TCR commonly found in subtype IV isolates, see below) is shown at the top, and the other sequences are shown below in relation to Seq-1. BKV isolates carrying each TCR sequence are shown in Table 5 .
Interestingly, we found a correlation between BKV subtypes and TCR structures. Thus, Seq-1, -4, -5 and -7 TCRs were commonly detected in subtypes IV, III, Ib and Ic, respectively (the TCRs of naturally occurring BKV strains belonging to subtypes II and Ia were not available). Seq-5 was detected in strain WW frequently referred to as the representative archetypal BKV strain. The subtype-specific TCR sequences (Seq-1, -4, -5 and -7) were distinguished from each other by single-nucleotide substitutions at 11 positions and by single-nucleotide deletions at 2 positions (Table 6 ).
The other TCR sequences (Seq-2, -3, -6, -8, -9 and -10) were probably derived from the consensus sequences in individual subtypes by nucleotide substitutions or sequence rearrangements (deletions or duplications). Thus, it was inferred that Seq-2 and -3 were generated from Seq-1; Seq-6 from Seq-5; and Seq-8 to -10 from Seq-7. Three sequences (Seq-3, -6 and -10) carried rather extensive rearrangements, involving deletions or duplications. However, these were detected in only three isolates.
DISCUSSION Distribution of BKV subtypes in human populations
BKV is the only primate polyomavirus that can be classified into antigenically distinct subgroups. In this study, we attempted to clarify the correlation between BKV subtypes and human populations. The distribution of BKV subtypes in human populations was previously studied in England, Tanzania and the United States (Jin et al., 1993b (Jin et al., , 1995 Agostini et al., 1995; Baksh et al., 2001) . In this study, we clarified the distribution of BKV subtypes in Japan. Although the populations studied varied in terms of the clinical state of the subjects, the results of the studies conducted so far suggest that subtype I is predominant in all human populations around the world. Isolates analysed by RFLP are not included.
Patient Geographical region
Isolate used for analysis Phylogenetic TCR RT Tohoku THK-1 to -4, -6, -8, -9 THK-2, -3, -5 to -9, -11 RT Tokyo TU-1, -2, TW-1 to -12 TW-1 to -8, -12 to -14 RT Okinawa RYU-1 to -8 RYU-1 to -5, -7, -8 BMT Tokyo KOM-1 to -31 KOM-1 to -3, -5 to -8, -10 to -16, -21, -26 to -30
However, relative proportions of the minor subtypes differed among populations studied. In renal transplant recipients (Jin et al., 1993b (Jin et al., , 1995 Baksh et al., 2001 ; this study), subtype IV was detected at lower rates and subtypes II and III were not or rarely detected. Jin et al. (1995) reported that dual BKV infection frequently occurred in HIV-infected patients and that subtype III was more often detected than in the other subject groups. The reactivation of BKV in HIV-positive patients remains to be investigated further. Fig. 1 . Phylogenetic tree used to classify the BKV isolates into subtypes. The 287 bp typing sequences detected in the present and previous studies were used to construct an NJ phylogenetic tree using CLUSTAL W (Thompson et al., 1994) . The phylogenetic tree was visualized using DendroMaker for Macintosh ver. 4.1. The tree was rooted at the midpoint, assuming various BKV strains evolved at roughly the same rate. Subtypes and possible subgroups within subtype I are indicated to the right of the tree. Asterisks identify isolates reported previously and used as references. Origins of isolates are shown in Tables 3 and 4 . The numbers at nodes give the bootstrap confidence level (%) obtained for 1000 replicates (only values ¢50 % are shown for major nodes). Molecular epidemiological studies of BKV conducted thus far (see above) suggest that there is no significant correlation between BKV subtypes and geographical regions. This is in striking contrast to the established correlation between JCV subtypes and geographical regions (Sugimoto et al., 1997; Agostini et al., 2001; Yogo et al., 2004) . However, it should be noted that the subtypes of BKV are antigenically distinguished, while those of JCV are only discernable in terms of nucleotide sequences. If it can be assumed that BKV and JCV have essentially the same evolutionary rate, it may be speculated that it took longer for the BKV subtypes than JCV subtypes to be generated. Thus, it is conceivable that BKV originated before the formation of modern humans (i.e. the four BKV subtypes would have already existed in ancestral populations of modern humans). In contrast, JCV subtypes would have been generated, after the emergence of modern humans, in association with the division of human populations (Yogo et al., 2004) .
Nevertheless, we consider that subgroups within each subtype may have a correlation with human populations.
In this study, we analysed many isolates from the Japanese population, and found that a majority of Japanese isolates occurred in Ic, suggesting a correlation between Japanese isolates and subgroup Ic. If a larger number of isolates derived from Europeans, Africans and Asians (other than Japanese) are sequenced and a phylogenetic tree is constructed using the resultant sequence data, a correlation between BKV subgroups and human populations will be evident.
Relationships between TCR structures and BKV subtypes
We compared TCR structures, and found that there were several nucleotide substitutions and a few single-nucleotide deletions (or insertions) among BKV subtypes. We sometimes detected BKV TCRs with rather extensive rearrangements, but the BKVs with these rearranged TCRs rarely predominated in a population. Thus, we concluded that the basic TCR structure (the so-called archetype configuration) were conserved among subtypes of BKV.
The TCR detected in strain WW has been considered to represent the archetypal TCR of BKV (Knowles, 2001) . Nevertheless, the present findings suggested that like other parts of the genome, the BKV TCR underwent evolutionary changes, involving nucleotide substitutions and singlenucleotide deletions/insertions. Thus, each subtype of BKV has a unique set of nucleotide substitutions and deletions/ insertions. We therefore suggest that 'archetype' be used as a conceptual word that denotes the prototypical structure that can generate various rearranged TCRs typically observed in BKV strains passaged in cell culture (Yoshiike & Takemoto, 1986; Hara et al., 1986; Rubinstein et al., 1987) . In this sense, TCR structures (e.g. Seq-1, -4, -5 and -7) shared by most isolates belonging to the same subtypes are all archetypal. Isolates cloned previously (Rubinstein et al., 1987; Sugimoto et al., 1989) are underlined.
TCR sequence* Subtype Isolate
Seq-1 IV THK-3, -7, TW-3, RYU-5, KOM-2, -7, -12 Seq-2 IV RYU-3 Seq-3 IV THK-8 Seq-4 III KOM-3, RYU-7 Seq-5 Ib THK-2, KOM-5, WW Seq-6 Ib KOM-1 Seq-7 Ic THK-5, -6, -9, -11, TW-1, 2, -4 to -7, -12 to -14, RYU-1, -4, -8, DIndicates deletion of a single nucleotide.
